title: [Secondary membranous nephropathy: The topics of membranous lupus nephritis].
authors.forename: Wako
authors.initials: W
authors.lastname: Yumura
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001379:Azathioprine / Q000008:administration & dosage; D065095:Calcineurin Inhibitors; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000008:administration & dosage; D015433:Glomerulonephritis, Membranous / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008181:Lupus Nephritis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology; D016685:Mitomycin / Q000008:administration & dosage; D011379:Prognosis; D012263:Ribonucleosides / Q000008:administration & dosage; D012673:Semustine / Q000008:administration & dosage; D016559:Tacrolimus / Q000008:administration & dosage
chemical_list: D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; D012673:Semustine; C010052:mizoribine; D016685:Mitomycin; D001379:Azathioprine; D005472:Fluorouracil; D016559:Tacrolimus